Defaz CI


Defaz CI


Stock Status:

In Stock

  • *Upload Prescription

    • (max file size 80 MB)


Indications of Defaz CI Capsule

Defaz CI Capsule is used to treat and prevent iron, folic acid, and zinc deficiency, particularly during pregnancy and lactation.


Pharmacology of Defaz CI Capsule

This timed-release capsule is the combined arrangement of Carbonyl Press, Folic Corrosive and Zinc Sulfate Monohydrate. It contains Carbonyl Press with not less than 98% Press substance. Carbinyl Press, having tall bioavailability and moo harmfulness is more secure and more viable choice for press supplementation.


Defaz CI Capsule Dosage & Administration

Adult: One Capsule daily before food or as directed by the physician.


Interaction of Defaz CI Capsule

Tetracycline antibiotics, quinolone antibiotics, levodopa, levothyroxine, methyldopa, and penecillamine are all affected by carbonyl iron. Because folic acid interacts with antiepileptic drugs, phenobarbital, phenytoin, and primidone plasma concentrations may be lowered.


Contraindications of Defaz CI Capsule

Gastrointestinal irritations such as nausea, anorexia, vomiting, discomfort, constipation and diarrhoea may occur.


Defaz CI Capsule Side Effects

Gastrointestinal disturbances such as queasiness, anorexia, spewing, inconvenience, stoppage and the runs may happen. Patients may complain of dull stool. Carbonyl Press pellets joined into the capsules to diminish the plausibility of gastrointestinal aggravations. Once in a while there may be unfavorably susceptible responses.


Pregnancy & Lactation

Utilize of any sedate amid to begin with trimester of pregnancy ought to be dodged in the event that conceivable. In this way organization of Press amid the primary trimester requires positive prove of Press insufficiency. Prophylaxis of Press insufficiency where insufficient count calories calls for supplementary Zinc and Folic corrosive is legitimized amid the leftover portion of pregnancy.


Precautions & Warnings

Uncommon care ought to be taken in patients with Press over-burden states, such as haemochromatosis, haemolytic frailty or ruddy blood cell aplasia. Disappointment to reaction to the treatment requires encourage examinations to prohibit other causes of frailty. In patients with renal disappointment there may be the chance of Zinc accumulation.


Therapeutic Class

Iron, Vitamin & Mineral Combined preparation.


Storage Conditions

Store at or below 30°C in a cool, dry location away from light and moisture. Keep out of reach of youngsters.


Pharmaceuticals name of Defaz CI Capsule

The ACME Laboratories Ltd



Carbonyl Iron + Folic Acid + Zinc Sulfate.